Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Using hydrogel polymers for drug delivery.

A M McNair1

  • 1Biocompatibles Ltd., Farnbam, UK.

Medical Device Technology
|November 3, 1996
PubMed
Summary

Cardiovascular disease is a major health concern. A new phosphorylcholine coating for coronary stents may reduce thrombosis and allow targeted drug delivery, minimizing systemic side effects.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same journal

Safer arterial access.

Medical device technology·2010
Same journal

Building better surfaces.

Medical device technology·2010
Same journal

PVC: a broader perspective.

Medical device technology·2010
Same journal

Joining and forming using torsional ultrasonic principles.

Medical device technology·2010
Same journal

US regulation of combination products.

Medical device technology·2010
Same journal

Assessing biological safety of metals associated with medical devices.

Medical device technology·2010

Area of Science:

  • Biomaterials Science
  • Cardiovascular Medicine
  • Drug Delivery Systems

Background:

  • Cardiovascular disease is a leading cause of death globally.
  • Coronary stenting improves outcomes for coronary artery disease but risks thrombosis.
  • Systemic drug delivery for cardiovascular conditions can cause adverse effects.

Purpose of the Study:

  • To evaluate a novel phosphorylcholine coating for coronary stents.
  • To assess the coating's nonthrombogenic properties.
  • To investigate its potential for localized drug incorporation and delivery.

Main Methods:

  • Evaluation of a phosphorylcholine-based coating material.
  • Assessment of thrombogenicity in a relevant model (details not specified in abstract).
  • Analysis of drug incorporation and release capabilities (details not specified in abstract).

Main Results:

  • The phosphorylcholine coating demonstrated nonthrombogenic characteristics.
  • The coating has the potential to incorporate and deliver drugs locally.
  • This approach may reduce systemic toxicity associated with current treatments.

Conclusions:

  • Phosphorylcholine coatings represent a promising advancement for coronary stents.
  • This technology could mitigate thrombosis risks and improve drug delivery efficacy.
  • Further research may lead to safer and more effective cardiovascular interventions.

Related Experiment Videos